Metis TechBio Co., Ltd. (HKG:7666)

Market Cap	26.92B
Revenue (ttm)	116.85M +6,985.0%
Net Income	-436.04M
EPS	-4.63
Shares Out	1.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,668,720
Average Volume	26,233,659
Open	23.32
Previous Close	23.36
Day's Range	19.12 - 23.32
52-Week Range	19.12 - 29.98
Beta	n/a
RSI	n/a
Earnings Date	n/a

About Metis TechBio

Metis TechBio Co., Ltd. engages in research and development of AI-empowered nanomaterial for the delivery and application of active agents across carbon-based life forms in Chinese Mainland and United States. It develops NanoForge, a suite of synergistic technologies that includes novo lipid library, AI foundational models, METiSAIAgent, quantum chemistry and molecular dynamics simulations, and AI-driven screening platforms. The company also develops specialized platforms, such as AiTEM, AiLNP and AiRNA that simulate, predict, and interpret nan...

• Founded: 2020
• Country: Hong Kong
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 7666

Financial Performance

In 2025, Metis TechBio's revenue was 105.00 million, an increase of 6985.02% compared to the previous year's 1.48 million. Losses were -391.84 million, -21.51% less than in 2024.

Financial numbers in CNY